$30,000 of GLOBAL MEDICAL RESPONSE lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare Sequestration. Medicaid Payment. Surprise Billing. VA Rates."
You can find more data on corporate lobbying on Quiver Quantitative.
GMRE Insider Trading Activity
GMRE insiders have traded $GMRE stock on the open market 9 times in the past 6 months. Of those trades, 8 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GMRE stock by insiders over the last 6 months:
- MARK OKEY JR DECKER (CEO and President) has made 7 purchases buying 190,894 shares for an estimated $1,254,353 and 0 sales.
- JAMIE ALLEN BARBER (General Counsel and Secretary) sold 130,000 shares for an estimated $861,068
- MATTHEW CYPHER purchased 1,350 shares for an estimated $9,960
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GMRE Hedge Fund Activity
We have seen 88 institutional investors add shares of GMRE stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN ADVISORY INC removed 1,616,524 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $11,202,511
- PHOCAS FINANCIAL CORP. removed 572,131 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,964,867
- STRS OHIO added 415,300 shares (+3810.1%) to their portfolio in Q2 2025, for an estimated $2,878,029
- GABELLI FUNDS LLC added 408,244 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,829,130
- INVESCO LTD. added 355,355 shares (+30.5%) to their portfolio in Q2 2025, for an estimated $2,462,610
- GOLDMAN SACHS GROUP INC added 341,232 shares (+87.8%) to their portfolio in Q2 2025, for an estimated $2,364,737
- MARSHALL WACE, LLP added 279,070 shares (+2208.2%) to their portfolio in Q2 2025, for an estimated $1,933,955
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
